How Ph.D. was paid
$4.7M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Options | Incentive | Other | Total |
|---|---|---|---|---|---|
| Todd C. Brady, M.D., Ph.D.President and Chief Executive Officer | $700,000 | $3,801,379 | $189,000 | $14,000 | $4,704,179 |
| Stephen G. Machatha, Ph.D.Chief Development Officer | $400,000 | $950,342 | — | $101,800 | $1,452,142 |
| Michael AlfieriPrincipal Financial Officer and Principal Accounting Officer | — | — | — | $243,994 | $245,963 |
What changed and why
- $4.7MCEO total compensation increased to $4,704,179 in fiscal 2025 from $3,931,645 in fiscal 2024.
- $700KDr. Brady received an annual base salary of $700,000 for fiscal 2025 compared to $591,631 in 2024.
- 45%The 2025 annual performance bonus was funded at 45% of target after evaluating corporate goals.
- $6.17Dr. Brady was granted an option to purchase 809,710 shares of common stock with an exercise price of $6.17.
- 70%At the 2025 annual meeting, the say-on-pay proposal received support from approximately 70% of votes cast.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.